Meso-Rex bypass for extrahepatic portal vein obstruction in children

Author:

Guérin F1,Bidault V1,Gonzales E2,Franchi-Abella S3,De Lambert G1,Branchereau S1

Affiliation:

1. Department of Paediatric Surgery, Bicêtre Hospital, Assistance Publique Hôpitaux de Paris, University Paris-Sud (Paris 11), 78 Rue du Général Leclerc, F94270, Le Kremlin-Bicêtre, France

2. Department of Paediatric Hepatology, Bicêtre Hospital, Assistance Publique Hôpitaux de Paris, University Paris-Sud (Paris 11), 78 Rue du Général Leclerc, F94270, Le Kremlin-Bicêtre, France

3. Department of Paediatric Radiology, Bicêtre Hospital, Assistance Publique Hôpitaux de Paris, University Paris-Sud (Paris 11), 78 Rue du Général Leclerc, F94270, Le Kremlin-Bicêtre, France

Abstract

Abstract Background Meso-Rex bypass (MRB) and portosystemic surgical shunt (PSS) are both used to treat extrahepatic portal vein obstruction (EHPVO) in children. The aim of this study was to analyse the outcome of MRB and PSS to select patients who could benefit from a prophylactic MRB. Methods This single-centre retrospective study of children who underwent either MRB or PSS for EHPVO was conducted between 1996 and 2010. Details of patient demographics and preoperative evaluation were collected. Success rates, defined as shunt patency after a minimum of 6 months and clearance of varices or symptoms, were compared. Determinants of outcomes were explored. Results Sixty-nine patients underwent a MRB or PSS. Median (interquartile range, i.q.r.) age at surgery was 6·6 (4·0–10·6) years. Twenty-four patients (35 per cent) had had a neonatal umbilical catheter (NUC) placed previously and 47 (68 per cent) had experienced an upper gastrointestinal bleed. Imaging assessment of the intrahepatic left portal vein was considered favourable in 40 patients. Of 43 MRBs attempted, 11 failed during surgery and four patients had persistent thrombosis after a median of 55 (i.q.r. 18–107) months. The success rate of MRB was 60 per cent (26 of 43) compared with 100 per cent (26 of 26) for PSS (P < 0·001). It was lower among patients in whom a NUC had been used (2 of 10 versus 24 of 33; P = 0·004), for procedures undertaken early in the series (6 of 16 versus 20 of 27; P = 0·020) and when the imaging pattern was unfavourable (0 of 5 versus 26 of 38; P = 0·006). On multivariable analysis, only a previous history of NUC predicted failure (P = 0·016). Conclusion Prophylactic MRB seems a good treatment option for EHPVO in children, but should be done only by an experienced team in patients with favourable imaging and without a previous history of NUC. Presented in part to the 43rd Annual Meeting of the American Pediatric Surgical Association, San Antonio, Texas, USA, May 2012

Publisher

Oxford University Press (OUP)

Subject

Surgery

Reference15 articles.

1. Extrahilar mesenterico-left portal shunt to relieve extrahepatic portal hypertension after partial liver transplant;de Ville de Goyet;Transplantation,1992

2. Recent concepts regarding extra-hepatic portal hypertension;Gauthier;Semin Pediatr Surg,2005

3. Liver nodules after portal systemic shunt surgery for extrahepatic portal vein obstruction in children;Guérin;J Pediatr Surg,2009

4. Mesenterico-left portal vein bypass in children with congenital extrahepatic portal vein thrombosis: a unique curative approach;Fuchs;J Pediatr Gastroenterol Nutr,2003

5. de Ville de Goyet J. Mesoportal bypass for extrahepatic portal vein obstruction in children: close to a cure for most!;Sharif;J Pediatr Surg,2010

Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3